PT
Paul F Truex
Director

Paul F Truex insider trades: Milestone Pharmaceuticals (MIST) stock buys and sales

Director, Milestone Pharmaceuticals Last trade May 31, 2022 55 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2010
4
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paul reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 31, 2022MIST↑ Buy$28K
Sep 7, 2017ANTH↑ Buy$7K
Jun 29, 2012ANTH↑ Buy$15K
Feb 15, 2012ANTH↓ Sell$118K
Jan 17, 2012ANTH↓ Sell$101K
Dec 15, 2011ANTH↓ Sell$95K
Nov 15, 2011ANTH↓ Sell$209K
Oct 21, 2011ANTH↓ Sell$145K
Oct 18, 2011ANTH↓ Sell$42K
Aug 29, 2011TSRX↑ Buy$14K
Jul 15, 2011ANTH↓ Sell$119K
Jun 15, 2011ANTH↓ Sell$125K
May 16, 2011ANTH↓ Sell$107K
Nov 23, 2010TSRX↑ Buy$4K
Mar 1, 2010ANTH↑ Buy$7K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MIST insiders

Open-market trades in the last 12 months

About Paul F Truex's insider trades

Paul F Truex is a director at Milestone Pharmaceuticals (MIST). Since Mar 1, 2010, Paul has reported 6 open-market purchases worth $74K and 9 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (27 filings), gifts (11 filings), option exercises (8 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.